Join haematopathologists, Dr Liron Barnea Slonim, and Dr Anna Green (chairing), and haematologist, Professor Karthik Ramasamy, for an educational webinar exploring diagnosis and treatment of Castleman's disease.

This educational webinar will provide insights to the pathological features of the various types of Castleman's disease, challenges in diagnosis with focus on iMCD, and emphasis on the need for a multidisciplinary approach to the patients. 

Meet the speakers

Dr Liron Barnea Slonim

Dr. Barnea Slonim received her medical degree from Sackler School of Medicine. She then completed anatomic and clinical pathology residency in the NYU Hospital system in NY, followed by a hematopathology fellowship at Northwestern University and a molecular genetics pathology Fellowship at University of Chicago. She is currently a consultant haematopathologist (subspecialty lead) and molecular pathologist in the South East London HMDS at King's College Hospital (KCH) NHS Foundation Trust in London, UK. Her interests include myeloid and lymphoid pathology and associated diagnostics as well as promoting haematopathology training. She recently created a fellowship training program at KCH, which she is hoping might roll out in other centres across the UK.

Professor Karhik Ramasamy

Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals NHS Trust and Professor of Haematology, NDORMS, University of Oxford UK. Prof Ramasamy is the Clinical Director of the Oxford Myeloma Translational Research Centre (https://www.ndorms.ox.ac.uk/research/otmc). Karthik is an active member of International Myeloma working Group and UK Myeloma Research Alliance. Karthik served on the Myeloma UK Board, a patient charity exclusively dealing with myeloma advocacy and research for two terms and currently holds an ambassadorial role. Prof Ramasamy is a Chief Investigator of national myeloma/ MGUS studies and his translational research interests are MGUS monitoring pathways, early intervention of smouldering myeloma, high risk myeloma and myeloma drug resistance mechanisms. Prof Ramasamy is the Research Lead for Cancer and Haematology at Oxford University Hospitals NHS Trust. Prof Ramasamy completed his haematology training in London. Following this, he completed a PhD in myeloma at King’s College London. Karthik has published over 175 papers and authored textbooks/ chapters on myeloma.

Dr Anna Green (chair)

Dr Anna Green is a Consultant Histopathologist at Guy’s and St Thomas’ NHS Foundation Trust, London UK, where she specialises in Haematopathology and Autopsy Pathology. Dr Green is also a Board Member of the European Bone Marrow Working Group, Council Member of the British Lymphoma Pathology Group and Council Member of the BDIAP.